Skip to Content

Pfizer 1 XNB (Inlyta 1 mg)

Generic Name: axitinib

Pill imprint Pfizer 1 XNB has been identified as Inlyta 1 mg.

Inlyta is used in the treatment of renal cell carcinoma and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Inlyta 1 mg is not a controlled substance under the Controlled Substance Act (CSA).

Inlyta 1 mg Pfizer 1 XNB
Discount Card Promo
Inlyta
Generic Name:
axitinib
Imprint:
Pfizer 1 XNB
Strength:
1 mg
Color:
Red
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Multikinase inhibitors
VEGF/VEGFR inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Pfizer Inc.
National Drug Code (NDC):
00069-0145
Inactive Ingredients:
microcrystalline cellulose
lactose monohydrate
croscarmellose sodium
magnesium stearate
titanium dioxide
triacetin
ferric oxide red
hypromellose 2910 (15000 mPa.s)

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide